Ophthalmic Drugs Market Analysis and Forecast to 2035: Type: Prescription Drugs, Over-the-Counter Drugs, Biologics, Biosimilars, Others| Product: Anti-inflammatory Drugs, Anti-infective Drugs, Anti-glaucoma Drugs, Anti-allergy Drugs, Retinal Disorder Drugs, Dry Eye Drugs, Others| Technology: Small Molecule Drugs, Biopharmaceuticals, Gene Therapy, Nanotechnology, Others| Application: Glaucoma, Cataract, Age-related Macular Degeneration (AMD), Diabetic Retinopathy, Dry Eye Syndrome, Uveitis, Others| Form: Tablets, Capsules, Eye Drops, Ointments, Gels, Injections, Others| End User: Hospitals, Ophthalmic Clinics, Ambulatory Surgical Centers, Homecare Settings, Others| Mode: Topical, Oral, Intravitreal, Periocular, Others| Stage: Discovery, Preclinical, Clinical Trials, Approval, Post-marketing Surveillance, Others|